2Malerba M, Pontieiello A, et al. Effect of twelve months therapy with oral ambroxol in preventing exacerbations in patients with COPD,double- blind,rando-mized,multicenter, placebo-controlled study (the METHIST- Trial)[J].Pulm pharmacol Ther, 2004,17(1):27-34.
3Kido H,Okumura Y,Yamada H,et al.Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential[J].Biol chem,2004,385(11):1029.
